Abstract
Clinical Features
-
Ascending symmetrical muscle weakness that evolves over several days to a week.
-
Nadir of neurologic deficit occurs by 28 days in 95% of cases.
-
Full recovery in 80% of patients.
-
Pain and aching discomfort in muscles.
-
Paraesthesias.
-
Hypotonia with absent reflexes.
-
Facial diplegia is common.
-
Autonomic dysfunction with fluctuating blood pressure and pulse, facial flushing, profuse diaphoresis.
-
Fisher syndrome: ophthalmoplegia, ataxia, areflexia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected Reference
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Lancet. 1997;349: 225–230.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Marik, P.E. (2001). Guillain-Barré Syndrome and Myasthenia Gravis. In: Handbook of Evidence-Based Critical Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-86943-3_41
Download citation
DOI: https://doi.org/10.1007/978-3-642-86943-3_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78093-9
Online ISBN: 978-3-642-86943-3
eBook Packages: Springer Book Archive